Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dr. Reddy's Laboratories Ltd Common Stock (RDY) vs State Street Corporation Common Stock (STT) Price & Performance

Dr. Reddy's Laboratories Ltd Common StockTrade
State Street Corporation Common StockTrade

Price performance (Past 24H)

Key statistics

Dr. Reddy's Laboratories Ltd Common Stock vs State Street Corporation Common Stock — how do they compare? Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B), while State Street Corporation Common Stock trades at $166.95 (market cap $47.83B). The key difference: State Street Corporation Common Stock is far larger — about 4.4× Dr. Reddy's Laboratories Ltd Common Stock's market cap, and State Street Corporation Common Stock pays the higher dividend (2.11%). Which is the better fit depends on your goals — on Pluang, investors hold Dr. Reddy's Laboratories Ltd Common Stock for 0 Days and State Street Corporation Common Stock for 2 Days on average.

RDYSTT
Market Cap
$10.78B$47.83B
Volume
2,724,3432,907,463
Sector
HealthFinancials
52-Week High
$15.38$194.26
52-Week Low
$11.38$111.37
Typical Hold Time
0 Days2 Days
Enterprise Value
$10.68B$74.34B
Dividend Yield
0.65%2.11%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dr. Reddy's Laboratories Ltd Common Stock

No Aura AI signal available yet.

State Street Corporation Common Stock

State Street (STT) trades at $173.99, down 0.54% with bearish technical signals despite strong Q3 2026 earnings beat. The stock faces headwinds from a revenue miss and ongoing investigation, though fundamentals show robust profitability with 22.95% net margin and consistent earnings growth. Analyst consensus remains positive with $183.55 price target, but technical indicators show selling pressure with support at $172.

Outlook is mixed with strong fundamentals supporting long-term value, but near-term risks from the securities investigation and bearish technicals create uncertainty. The 13% revenue growth and record AUM provide upside potential, though investors should monitor legal developments and expense trends that could impact sentiment.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RDY
100% Buy0% Sell
Avg holding period · 0 Days
STT
100% Buy0% Sell
Avg holding period · 2 Days

Top news

Latest headlines on both assets

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →

About State Street Corporation Common Stock

State Street provides investment servicing, custody, and asset management services to institutional investors. Its asset management business includes the SPDR ETF range.

Read more on STT →